Hitoshi Harada

This inventor holds 17 USPTO granted patents, plus 3 CIPO patents and 1 EPO patent. Top assignees: Eisai R&d Management Co., Ltd., Eisai Company, Limited. Active years: 2003-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hitoshi Harada. Retrieved from https://idiyas.com/inventor/hitoshi-harada-5lt9m4nl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17

% Patents Active = 11.8

CIPO Patents = 3

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 8.5

ph-index = 5

Forward Citations = 274(Granted Patents)

Location History:

Ushiku, JP (2006)
Tsukuba, JP (2008 - 2012)
Ibaraki, JP (2003 - 2013)

Company Filing History:

9 out of 530

Eisai R&d Management Co., Ltd.

patents

8 out of 677

Eisai Company, Limited

patents

Years Active: 2003-2013

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8476301 - Pyrrolidin-3-ylacetic acid derivative (2013-07-02),

2. 8124780 - Benzimidazole compound (2012-02-28),

3. 7781452 - Imidazopyridine compound (2010-08-24),

4. 7767812 - Crystals of pyrimidine compound and process for producing the same (2010-08-03),

5. 7544835 - Carboxylic acid derivative and salt thereof (2009-06-09),

6. 7538117 - Crystalline and amorphous pyrimidine compounds and processes for preparing pyrimidine compounds (2009-05-26),

7. 7425634 - Benzimidazole compound (2008-09-16),

8. 7396928 - Crystals of 5-[2-amino-4-(2-furyl) pyrimidin-5-yl]-1-methylpyridin-2(1H)-one and processes for preparing the same (2008-07-08),

9. 7396836 - Pyrimidine compound and medicinal composition thereof (2008-07-08),

10. 7253178 - Carboxylic acids (2007-08-07),

11. 7189717 - Medicinal compositions promoting bowel movement (2007-03-13),

12. 7160892 - Pyrimidone compounds and pharmaceutical compositions containing the same (2007-01-09),

13. RE39112 - Purine derivatives and adenosine A2 receptor antagonists serving as preventives/remedies for diabetes (2006-05-29),

14. 6884821 - Carboxylic acid derivatives and drugs containing the same (2005-04-26),

15. 6841549 - Condensed imidazole compounds and a therapeutic agent for diabetes mellitus (2005-01-11),

Title: The Innovative Mind of Hitoshi Harada

Introduction

Hitoshi Harada, an accomplished inventor based in Ibaraki, Japan, has made significant contributions to the field of pharmaceuticals through his 17 patents. His pioneering work focuses on developing compounds with medicinal potential, especially in the areas concerning acid-related diseases and pathways relevant to therapeutic interventions.

Latest Patents

Among Hitoshi Harada's latest innovations is the patent for a Pyrrolidin-3-ylacetic acid derivative, which represents a compound formula that exhibits an inhibitory effect in the fractalkine-CX3CR1 pathway. This patent details a structure where R signifies a Calkyl group, a Ccycloalkyl group, or a Ccycloalkenyl group, with additional complexity in its substituents. Furthermore, his benzimidazole compound is notable for its therapeutic potential against acid-related diseases, showcasing an excellent capacity to inhibit gastric acid secretion while maintaining an elevated intragastric pH over prolonged periods. This compound is characterized by various substituents and structural components that enhance its stability and safety.

Career Highlights

Hitoshi Harada has collaborated with leading organizations during his career, including Eisai R&D Management Co., Ltd. and Eisai Company, Limited. His efforts in these prominent companies have advanced pharmaceutical research and strengthened the foundations of drug development.

Collaborations

Throughout his career, Harada has worked alongside esteemed colleagues such as Osamu Asano and Nobuyuki Yasuda. These collaborations have helped to amplify the impact of his inventions and facilitated the exploration of novel therapeutic avenues.

Conclusion

Hitoshi Harada's innovative spirit and dedication to research highlight the transformative power of invention in the medical field. His contributions through patents and collaborative efforts continue to inspire progress in pharmaceutical science, potentially improving treatment options for many individuals.

Profile summary based on public USPTO records.